
Understanding PAPP-A Clinical Trials in ADPKD
Free
- Length
- 1 hr
- Platform
- Zoom
- Topic
- Medical & Clinical
About this webinar
This webinar will provide evidence-based information about the emerging PAPP-A treatment pathway and what it might mean for people living with autosomal dominant polycystic kidney disease (ADPKD).
Through an engaging discussion with ADPKD experts, we’ll explore this promising new treatment strategy and an overview of the three ongoing clinical trials investigating therapies that target the PAPP-A pathway. We’ll also share resources to learn more about clinical trials and how to get involved.
You’ll learn:
What PAPP-A is
The role researchers believe PAPP-A may play in the development and progression of ADPKD and why it’s an area of scientific interest
Details on three ongoing PAPP-A clinical studies
Who Should Attend?
People living with ADPKD
Caregivers/Parents
Clinicians
Speakers:
Eduardo Chini, M.D., Ph.D., Mayo Clinic, Jacksonville
Chris Chen, Ph.D., VP of Research Programs, PKD Foundation
Moderator: Paul Scribner, VP of Community Programs and Education



